MYDA Advisors’s Medifast MED Stock Holding History

MYDA Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-28,300	Closed	-$2.65M	–	176
2018 Q1	$2.65M	Buy	+28,300	New	+$2.11M	1.8%	14

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

MYDA Advisors's MED Position: Q2 2018 in Review

MYDA Advisors sold out of Medifast (MED) in Q2 2018, closing a stake of 28,300 shares — an estimated $2.65M sold.

MYDA Advisors first reported a position in MED in Q1 2018 and held it in 1 quarter. The position peaked at $2.65M in Q1 2018. 258 funds tracked by Wall St. Rank hold MED as of Q2 2018.

MYDA Advisors reported no remaining Medifast position as of Q2 2018 after selling out during the quarter.
MYDA Advisors sold 28,300 Medifast shares in Q2 2018, an estimated $2.65M.
MYDA Advisors first reported a position in Medifast in Q1 2018 and held it in 1 quarter.
MYDA Advisors's Medifast position peaked at $2.65M in Q1 2018.
258 funds tracked by Wall St. Rank held Medifast as of Q2 2018.

Based on MYDA Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.